Pacific Biosciences of California Inc. buy Zacks Research
Start price
21.02.26
/
50%
€1.37
Target price
21.02.27
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 21.02.27. The prediction end date can be changed by Zacks_Research at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Pacific Biosciences of California Inc. | - |
| iShares Core DAX® | 1.432% |
| iShares Nasdaq 100 | 1.892% |
| iShares Nikkei 225® | -1.619% |
| iShares S&P 500 | 1.921% |
Comments by Zacks_Research for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (NASDAQ:PACB) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for PACB provided by MarketBeat